AAPL   320.00 (+0.59%)
MSFT   181.81 (+0.00%)
FB   225.36 (-1.65%)
GOOGL   1,428.49 (+0.42%)
AMZN   2,412.35 (+0.08%)
CGC   21.44 (+7.74%)
MU   46.75 (-5.46%)
GE   6.81 (-6.72%)
TSLA   809.94 (-1.25%)
AMD   52.03 (-1.35%)
T   31.18 (-2.10%)
ACB   15.38 (+0.46%)
GILD   75.58 (+0.84%)
DIS   116.53 (-4.11%)
NFLX   414.89 (-0.92%)
BAC   25.05 (-3.58%)
AAPL   320.00 (+0.59%)
MSFT   181.81 (+0.00%)
FB   225.36 (-1.65%)
GOOGL   1,428.49 (+0.42%)
AMZN   2,412.35 (+0.08%)
CGC   21.44 (+7.74%)
MU   46.75 (-5.46%)
GE   6.81 (-6.72%)
TSLA   809.94 (-1.25%)
AMD   52.03 (-1.35%)
T   31.18 (-2.10%)
ACB   15.38 (+0.46%)
GILD   75.58 (+0.84%)
DIS   116.53 (-4.11%)
NFLX   414.89 (-0.92%)
BAC   25.05 (-3.58%)
AAPL   320.00 (+0.59%)
MSFT   181.81 (+0.00%)
FB   225.36 (-1.65%)
GOOGL   1,428.49 (+0.42%)
AMZN   2,412.35 (+0.08%)
CGC   21.44 (+7.74%)
MU   46.75 (-5.46%)
GE   6.81 (-6.72%)
TSLA   809.94 (-1.25%)
AMD   52.03 (-1.35%)
T   31.18 (-2.10%)
ACB   15.38 (+0.46%)
GILD   75.58 (+0.84%)
DIS   116.53 (-4.11%)
NFLX   414.89 (-0.92%)
BAC   25.05 (-3.58%)
AAPL   320.00 (+0.59%)
MSFT   181.81 (+0.00%)
FB   225.36 (-1.65%)
GOOGL   1,428.49 (+0.42%)
AMZN   2,412.35 (+0.08%)
CGC   21.44 (+7.74%)
MU   46.75 (-5.46%)
GE   6.81 (-6.72%)
TSLA   809.94 (-1.25%)
AMD   52.03 (-1.35%)
T   31.18 (-2.10%)
ACB   15.38 (+0.46%)
GILD   75.58 (+0.84%)
DIS   116.53 (-4.11%)
NFLX   414.89 (-0.92%)
BAC   25.05 (-3.58%)
Log in

NASDAQ:ACRXAcelRx Pharmaceuticals Earnings Date, Estimates & History

$1.51
-0.04 (-2.89 %)
(As of 05/28/2020 03:37 PM ET)
Add
Compare
Today's Range
$1.51
Now: $1.51▼
$1.58
50-Day Range
$1.28
MA: $1.45▼
$1.69
52-Week Range
$0.70
Now: $1.51▼
$3.02
Volume16,640 shs
Average Volume1.10 million shs
Market Capitalization$121.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.84

Earnings

AcelRx Pharmaceuticals (NASDAQ:ACRX) Earnings Information

AcelRx Pharmaceuticals last issued its earnings data on May 11th, 2020. The specialty pharmaceutical company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.03. The company earned $0.39 million during the quarter, compared to analysts' expectations of $2.65 million. AcelRx Pharmaceuticals has generated ($0.67) earnings per share over the last year. AcelRx Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 3rd, 2020 based off prior year's report dates.

AcelRx Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AcelRx Pharmaceuticals (NASDAQ:ACRX) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.16)($0.16)($0.16)

AcelRx Pharmaceuticals (NASDAQ ACRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/3/2020
(Estimated)		       
5/11/20203/31/2020($0.17)($0.20)($0.20)$2.65 million$0.39 millionTranscript
3/16/202012/31/2019($0.20)($0.18)($0.18)$1.23 million$0.48 millionTranscript
11/6/2019Q3 2019($0.23)($0.16)($0.16)$1.22 million$0.61 millionTranscript
8/5/2019Q2 2019($0.23)($0.16)($0.16)$1.55 million$0.94 millionTranscript
5/8/20193/31/2019($0.23)($0.17)($0.17)$0.85 million$0.27 millionTranscript
3/7/2019Q4($0.20)($0.18)($0.18)$3.10 million$0.61 millionTranscript
11/5/2018Q3 2018($0.2020)($0.2080)($0.21)$1.10 million$0.38 millionN/A
8/2/2018Q2($0.19)($0.20)($0.20)$0.93 million$0.82 millionN/A
5/9/2018Q1($0.24)($0.23)($0.23)$0.78 million$0.34 millionN/A
3/8/2018Q4 2017($0.20)($0.20)($0.20)$2.90 million$0.74 millionN/A
11/9/2017Q3 2017($0.26)($0.28)($0.28)$2.46 million$1.49 millionN/A
8/1/2017Q2 2017($0.28)($0.29)($0.29)$2.63 million$2.66 millionListen
5/8/2017Q1 2017($0.28)($0.34)($0.34)$2.36 million$3.11 millionListen
3/2/2017Q4 2016($0.23)($0.21)($0.21)$3.05 million$6.44 millionListen
11/1/2016Q316($0.23)($0.25)($0.25)$2.89 million$1.60 millionN/A
7/28/2016Q216($0.22)($0.24)($0.24)$2.17 million$4.53 millionListen
5/2/2016Q1 2016($0.22)($0.22)($0.19)$2.05 million$3.03 millionN/A
3/7/2016Q415($0.10)($0.24)($0.24)$4.97 million$1.73 millionListen
10/29/2015Q315($0.23)$0.11$0.11$1.75 million$13.90 millionListen
8/3/2015Q215($0.26)($0.20)($0.20)$0.30 million$1.92 millionListen
5/4/2015Q115($0.28)($0.27)($0.27)$0.40 million$0.18 millionN/A
3/9/2015Q4 2014($0.33)($0.32)($0.32)$0.23 millionN/A
11/10/2014Q4 2014($0.33)($0.32)($0.32)$4.95 million$4.83 millionN/A
8/11/2014Q214($0.27)($0.34)($0.38)$0.20 million$0.07 millionN/A
5/8/2014Q114($0.23)($0.22)($0.22)$0.28 million$0.10 millionN/A
3/3/2014Q4 2013($0.18)$0.18($0.05)$4.93 million$27.60 millionN/A
11/5/2013Q3 2013($0.18)($0.21)($0.16)$0.40 million$0.55 millionN/A
8/12/2013Q2 2013($0.25)($0.22)$0.03$1.73 million$0.41 millionListen
5/8/2013Q1 2013($0.26)($0.34)($0.34)$0.68 million$0.94 millionN/A
3/12/2013Q4 2012($0.39)($0.41)($0.41)N/A
11/6/2012Q312($0.38)($0.38)N/A
8/9/2012Q2 2012($0.39)($0.35)($0.35)N/A
5/8/2012Q1 2012($0.35)($0.36)($0.36)N/A
3/20/2012Q4 2011($0.39)($0.33)($0.33)N/A
11/8/2011Q3 2011($0.34)($0.30)($0.30)N/A
8/11/2011Q2 2011($0.32)($0.25)($0.25)N/A
5/12/2011Q1 2011($0.22)($0.30)($0.30)N/A
3/24/2011Q4 2010($5.23)($5.23)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/28/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.